BIO
Delivering GMP plasmid manufacturing with certainty
Offering integrated RNA and virotherapy capabilities, ReciBioPharm leverages experience and expertise to produce high-quality plasmid DNA (pDNA).
Our full-circle offering ensures the best start for your RNA and virotherapy on the journey from clinical trials to commercialisation.
Rely on quality plasmid manufacturing
Our in-house expertise in vector design and process development allows us to consistently deliver high-quality final pDNA products.
You can rely on us as a trusted source for your GMP plasmid, produced in Grade C cleanroom suites with rigorous quality assurance supervision.
- GMP plasmid as a starting material
- smGMP plasmid as a drug substance
- cGMP production of master and working cell banks (MCB/WCB)
- E. coli strain screening
- Fermentation optimisation
- Plasmid linearisation and clean-up
- Sterile fill and finish
Capabilities infused with flexibility
Leverage our extensive plasmid development and manufacturing experience and in-house expertise to accelerate your timelines while achieving the highest quality.
Through innovation, our comprehensive, streamlined plasmid production platform and capabilities are designed to help meet the diverse demands of your RNA and virotherapy project.
We give you the flexibility to either take advantage of our trusted platform process for quick turnaround times or allow us to harness your processes to achieve your desired result.
- 30 L and 300 L single-use fermenter
- Single-use downstream TFF and chromatography purification systems
- In-house qualified platform analytics
- Facilities and quality systems that support manufacturing from phase 1 to commercial
- Aseptic filling using a state-of-the-art integrated gloveless robotic isolator with advanced automation
Want to know more about our full biologics service offering?